Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Objective. To determine the efficacy and safety of Lingmao Formula combined with entecavir for HBeAg-positive chronic hepatitis B patients with mildly elevated alanine aminotransferase (ALT). Methods. 301 patients were randomly assigned to receive Lingmao Formula combined with entecavir (treatment g...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao-Jun, Sun, Xue-Hua, Zhou, Zheng-Hua, Liu, Shun-Qing, Lv, Hua, Li, Man, Li, Lu, Gao, Yue-Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766552/
https://www.ncbi.nlm.nih.gov/pubmed/24058372
http://dx.doi.org/10.1155/2013/620230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766552/
https://www.ncbi.nlm.nih.gov/pubmed/24058372
http://dx.doi.org/10.1155/2013/620230

Ejemplares similares